investigation of the effects of pilates training in patients with drug-resistant epilepsy

Conditions: Epilepsy; Cognitive Dysfunction; Seizures; Quality of Life; Sleep; Depression

Summary: this study was planned to examine the effects of pilates training in patients with drug-resistant epilepsy. it was planned to include 40 epilepsy patients in the study. the control group was planned to continue routine drug treatment for 8 weeks. the pilates group was planned to receive pilates training 3 days a week for 8 weeks in addition to routine drug treatment. it was aimed to examine the effects of pilates training performed 3 times a week for 8 weeks on seizure frequency, core stability, balance, functional exercise capacity, cognitive functions, dual task, fatigue, kinesiophobia, sleep quality, depression and quality of life in patients with drug-resistant epilepsy.

this study was planned to investigate the effects of pilates training, a "core" stability-based exercise method that improves body alignment, postural control, and balance in patients with drug-resistant epilepsy, on seizure frequency, core stability, balance, functional exercise capacity, cognitive functions, dual task, fatigue, kinesiophobia, sleep quality, depression, and quality of life. it was planned to include 40 epilepsy patients in the study. the patients were planned to be randomly divided into two groups as pilates (n: 20) and control (n: 20). the control group was planned to continue routine drug treatment for 8 weeks. the pilates group was planned to receive pilates training 3 days a week for 8 weeks in addition to routine drug treatment. seizure frequency with the seizure diary; the "core" power with the "sit-ups" and the modified "push-ups" tests; the "core" endurans with the lateral bridge, the trunk flexor endurance, the prone bridge and the modified "biering-sorensen" tests; balance with the balance error scoring system (bess) and the four-step square test (fstt); functional exercise capacity with the 6-minute walk test (6-mwt); functional mobility and dual task with the timed up and go test (tug); cognitive functions with the bilnot battery; fatigue with the fatigue severity scale (fss); kinesiophobia with the tampa kinesiophobia scale; sleep quality with the pittsburgh sleep quality index (psqi); depression with the neurological disorders depression inventory in epilepsy (nddi); and health-related quality of life with the quality of life in epilepsy scale (qolie-31) were evaluated before and after treatment.

Eligibility criteria:
inclusion criteria: * being between the ages of 18-65 * being diagnosed with idiopathic refractory epilepsy by a specialist neurologist * not having had status epilepticus for 1 year before the study * being able to walk independently * not having participated in a regular exercise program * having a standardized mini mental test score greater than 24 * antiepileptic drug doses being stable during the study exclusion criteria: * history of any diagnosed neurological or neuropsychiatric disease other than epilepsy * presence of any cardiovascular, pulmonary, orthopedic or other medical conditions that would limit participation in the study * pregnancy and breastfeeding

Keywords: epilepsy cognitive dysfunction seizures quality of life sleep depression